Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
41
PSCH Quote, Financials, Valuation and Earnings
Last price:
$42.14
Seasonality move
:
2.09%
Day range:
$41.91 - $42.91
52-week range:
$39.95 - $49.05
Dividend yield:
0.28%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
8.4K
Avg. volume:
14K
1-year change:
0.92%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$42.64 | -- | -- | -- | $0.02 | 0.28% | -- |
|
BBH
VanEck Biotech ETF
|
$164.34 | -- | -- | -- | $1.25 | 0.76% | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
$61.49 | -- | -- | -- | $0.00 | 0% | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$40.23 | -- | -- | -- | $0.03 | 0.06% | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
$31.14 | -- | -- | -- | $1.17 | 3.77% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$87.13 | -- | -- | -- | $0.00 | 0.15% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 2.008 | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | 1.155 | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 1.217 | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 1.594 | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.265 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.588 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
Invesco S&P SmallCap Health Care ETF vs. Competitors
-
Which has Higher Returns PSCH or BBH?
VanEck Biotech ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- BBHVanEck Biotech ETF-- -- -- -
What do Analysts Say About PSCH or BBH?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than VanEck Biotech ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than VanEck Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 BBHVanEck Biotech ETF0 0 0 -
Is PSCH or BBH More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 1.020, which suggesting that the stock is 1.957% more volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.789, suggesting its less volatile than the S&P 500 by 21.104%.
-
Which is a Better Dividend Stock PSCH or BBH?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.28%. VanEck Biotech ETF offers a yield of 0.76% to investors and pays a quarterly dividend of $1.25 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or BBH?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- BBHVanEck Biotech ETF-- -- -- --
-
Which has Higher Returns PSCH or BBP?
Virtus LifeSci Biotech Products ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- -
What do Analysts Say About PSCH or BBP?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than Virtus LifeSci Biotech Products ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 BBPVirtus LifeSci Biotech Products ETF0 0 0 -
Is PSCH or BBP More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 1.020, which suggesting that the stock is 1.957% more volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.678, suggesting its less volatile than the S&P 500 by 32.175%.
-
Which is a Better Dividend Stock PSCH or BBP?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.28%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or BBP?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- --
-
Which has Higher Returns PSCH or PTH?
Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -
What do Analysts Say About PSCH or PTH?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 -
Is PSCH or PTH More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 1.020, which suggesting that the stock is 1.957% more volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.902, suggesting its less volatile than the S&P 500 by 9.824%.
-
Which is a Better Dividend Stock PSCH or PTH?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.28%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 0.06% to investors and pays a quarterly dividend of $0.03 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or PTH?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- --
-
Which has Higher Returns PSCH or SBIO?
ALPS Medical Breakthroughs ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat ALPS Medical Breakthroughs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- -
What do Analysts Say About PSCH or SBIO?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Medical Breakthroughs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than ALPS Medical Breakthroughs ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than ALPS Medical Breakthroughs ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 SBIOALPS Medical Breakthroughs ETF0 0 0 -
Is PSCH or SBIO More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 1.020, which suggesting that the stock is 1.957% more volatile than S&P 500. In comparison ALPS Medical Breakthroughs ETF has a beta of 0.934, suggesting its less volatile than the S&P 500 by 6.615%.
-
Which is a Better Dividend Stock PSCH or SBIO?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.28%. ALPS Medical Breakthroughs ETF offers a yield of 3.77% to investors and pays a quarterly dividend of $1.17 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. ALPS Medical Breakthroughs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or SBIO?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than ALPS Medical Breakthroughs ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than ALPS Medical Breakthroughs ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while ALPS Medical Breakthroughs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for ALPS Medical Breakthroughs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- --
-
Which has Higher Returns PSCH or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About PSCH or XBI?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is PSCH or XBI More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 1.020, which suggesting that the stock is 1.957% more volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 1.028, suggesting its more volatile than the S&P 500 by 2.824%.
-
Which is a Better Dividend Stock PSCH or XBI?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.28%. SPDR S&P Biotech ETF offers a yield of 0.15% to investors and pays a quarterly dividend of $0.00 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or XBI?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 2.29% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.2% over the past day.
Sell
47
CELH alert for Mar 18
Celsius Holdings [CELH] is up 0.3% over the past day.
